Global Lab Automation in Protein Engineering Market
Global Lab Automation in Protein Engineering Market is expected to reach US$ 2,710Mn by 2026 from US$ 1,073.01 Mn in 2018 at CAGR of 14.15%.
Lab automation in protein engineering market report helps to cover the marketplace and internal & external factors which could impact the automation industry. The increasing demand for protein drugs over non-protein drugs along with high incidences of lifestyle diseases is one of the key drivers for automation in the protein engineering market globally. Other drivers such as positive regulation of government for protein engineering and the need for consistency in quality.
Lack of planning for technology development, improperly trained personnel and high initial setup cost and low priority for lab automation among small and medium-sized laboratories hampering the Global Lab Automation in Protein Engineering Market.
Monoclonal antibodies segment is expected to grow at the highest XX% CAGR during the forecast period. Monoclonal antibodies are widely used as diagnostic and research reagents also in human therapy. This growth is attributed to the rise in adoption of them for various therapies such as cancer and autoimmune diseases.
Software and informatics segment is expected to grow at the highest XX% CAGR during the forecast period. The software can be used to improve electron density maps throughout a statistical approach in combining experimental X-ray diffraction data with information about the expected characteristics of an electron map. Automation of instrument helpful to understand and solve the mysteries of protein dysfunction, as well as mis-folding, aggregation, and abnormal movement.
On the basis of region Global Lab Automation in Protein Engineering Market divided into five regions such as Asia Pacific, North America, Europe, Latin America, and Middle East Africa. Among all the regions, North America had the XX% market share in 2018 and is projected to lead the market during the forecast period. Because of dominating the lab automation in protein engineering market globally and growing outsourcing pharmaceutical manufacturing to these regions due to the availability of cheaper labour and resources. Strict regulations imposed by the US government and the FDA, increasing demand in the diagnostic market, a growing emphasis on the drug discovery and research labs, and the rising presence of numerous diseases in North America have fueled the growth.
Key players operating in global automation in protein engineering market, Thermo Fisher Scientific, Danaher, Hudson Robotics, Becton Dickinson, Synchron Lab Automation, Agilent Technologies, Siemens Healthcare, Tecan Group Ltd, Perkinelmer, Honeywell International, Bio-Rad, Roche Holding AG, Eppendorf AG, Shimadzu, Aurora Biomed.
For More Information Visit @:https://www.maximizemarketresearch.com/market-report/global-lab-automation-in-protein-engineering-market/22288/
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Address: Pune, Maharashtra 411051, India.